SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory. The alliance is a partnership between Illumina, Merck KGaA, Darmstadt, Germany, and Genea, which develops innovative fertility technologies.
Help employers find you! Check out all the jobs and post your resume.
